Does ENZALUTAMIDE Cause Pathological fracture? 41 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Pathological fracture have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.1% of all adverse event reports for ENZALUTAMIDE.
41
Reports of Pathological fracture with ENZALUTAMIDE
0.1%
of all ENZALUTAMIDE reports
6
Deaths
20
Hospitalizations
How Dangerous Is Pathological fracture From ENZALUTAMIDE?
Of the 41 reports, 6 (14.6%) resulted in death, 20 (48.8%) required hospitalization.
Is Pathological fracture Listed in the Official Label?
Yes, Pathological fracture is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Pathological fracture?
DENOSUMAB (634)
LENALIDOMIDE (260)
DEXAMETHASONE (201)
ALENDRONATE (200)
ZOLEDRONIC ACID (185)
RISEDRONATE (110)
ADALIMUMAB (93)
LETROZOLE (87)
RITUXIMAB (87)
CYCLOPHOSPHAMIDE (85)
Which ENZALUTAMIDE Alternatives Have Lower Pathological fracture Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE